]>
IRCT20240204060891N1 IRCT 2024-02-15 Shahre-kord University of Medical Sciences Investigating the effect of budesonide nebulizer on healing and treatment process of children with pneumonia aged 1month to 5 years: a randomized clinical trial Investigating the effect of budesonide nebulizer on healing and treatment process of children with pneumonia aged 1 month to 5 years: a randomized clinical trial 2024-03-05 anticipated 110 Complete https://irct.ir/trial/75363 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The allocation of participants into 2 groups will be done randomly and by block method. The random assignment sequence is performed using a computer program. The random permutation method with the size of random blocks 2, 4, and 6 (because the last person in each block is not known) will be used to assign people to two groups receiving medicine, including 61 people, and the control group, including 61 people. 3 community acquired pneumonia. Intervention 1: Intervention group: budesonide recipient group. Intervention 2: Control group: The group not receiving budesonide. Yes - There is a plan to make this available What will be shared: The information obtained from the patients includes height, weight, BMI, hospitalization history, smoking and smoking in the family, urban or rural residence, and can be shared When: Access period starts 6 months after publication To whom: our Data available for Researchers working in academic and scientific institutions Conditions: Data analysis is allowed only for research purposes in centers and academic institutions and academies in compliance with medical ethics Where to obtain: The application should be submitted to the email below and the applicant's information including the name and surname, academic degree and academic or research center of the individual should be sent How to obtain: After sending the email, your request will be answered within 1 working week Comments:
public Mahsa Banitalebi
Hajar hospital., paraster street
Shahre-kord Iran (Islamic Republic of) 8816854633 +98 38 3222 0016 st-banitalebi@skums.ac.ir Shahre-kord University of Medical Sciences scientific Mahsa Banitalebi
Hajar hospital., paraster street
Shahre-kord Iran (Islamic Republic of) 8816854633 +98 38 3222 0016 st-banitalebi@skums.ac.ir Shahre-kord University of Medical Sciences Iran (Islamic Republic of) age between 1 month to 5 years community acquired pneumonia diagnosed by pediatrician Informed consent of the child's family to enter the study Observing and recording complete symptoms of patient during treatment 1 month 5 years Both Metabolic disorder cardiovascular disorder hyper reactive airway disease coagulopathy psychological disorder diabetes Immunocompromised patients Discontinuation of standard treatment for any possible reason Reluctance to continue treatment Treatment - Drugs N/A Intervention group: budesonide recipient group Control group: The group not receiving budesonide Average score of PRESS. Timepoint: Measuring the PRESS score before the study, on days 1, 2, 3, 4, and 5 and after the end of the trial. Method of measurement: Pediatric Respiratory Severity Score (PRESS). Shahre-kord University of Medical Sciences Approved 2023-11-15 Ethics committee of shahrekord University of Medical Sciences Clinical Research Development Unit of Hajar Hospital, Shahrekord, Nurse St., Hajar Hospital shahrekord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)